![Nathan LiaBraaten](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Nathan LiaBraaten
Investor Relations Contact at
SUMMIT THERAPEUTICS INC.
Profile
Nathan Michael LiaBraaten is Senior Director-Investor Relations at Summit Therapeutics, Inc. since 2024.
Former roles include Director-External Affairs at The University of Oregon Investment Group and Research Associate at Stonepine Capital Management LLC.
Education includes an undergraduate degree (2005) and an MBA (2006) from the University of Oregon.
Nathan LiaBraaten active positions
| Companies | Position | Start |
|---|---|---|
| SUMMIT THERAPEUTICS INC. | Investor Relations Contact | 2023-12-31 |
Former positions of Nathan LiaBraaten
| Companies | Position | End |
|---|---|---|
Stonepine Capital Management LLC
 Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Analyst-Equity | - |
The University of Oregon Investment Group
 The University of Oregon Investment Group Investment ManagersFinance UOIG utilizes tactics of fundamental equity valuation, actively manages two portfolios, and takes several educational trips throughout the year, they give its members an extremely valuable and unique opportunity to explore finance. The firm utilizes two primary quantitative valuation methods in order to estimate the intrinsic value of a company: Comparables Analysis and Discounted Cash Flows Analysis (DCF). | Analyst-Equity | - |
Training of Nathan LiaBraaten
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
79
1st degree connections
4
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
Stonepine Capital Management LLC
Stonepine Capital Management LLC Investment ManagersFinance Stonepine aims to achieve superior absolute returns while preserving capital primarily by investing its assets in publicly traded healthcare companies. Their investment focus is companies with commercial stage products generating sustainable revenue and companies with substantial financial assets (such as cash and royalty income streams). The firm looks for companies whose valuations reflect a material discount to their fundamental value in the healthcare space. | Finance |
The University of Oregon Investment Group
The University of Oregon Investment Group Investment ManagersFinance UOIG utilizes tactics of fundamental equity valuation, actively manages two portfolios, and takes several educational trips throughout the year, they give its members an extremely valuable and unique opportunity to explore finance. The firm utilizes two primary quantitative valuation methods in order to estimate the intrinsic value of a company: Comparables Analysis and Discounted Cash Flows Analysis (DCF). | Finance |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Summit Therapeutics, Inc.
 Summit Therapeutics, Inc. BiotechnologyHealth Technology Develops biopharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Nathan LiaBraaten
